ACC American College of Cardiology, AHA American Heart Association, ESC European Society of Cardiology, ADA American Diabetes Association, GLP-1 RA glucagon-like peptide 1 receptor agonists, T2DM type 2 diabetes mellitus, ASCVD atherosclerotic cardiovascular disease, CV cardiovascular, CVD cardiovascular disease, MACE major adverse cardiovascular event, SGLT2i sodium-glucose co-transporter 2 inhibitors, BMI body mass index, MI myocardial infarction, HFpEF heart failure with preserved ejection fraction a ACC/AHA and ESC utilize class of recommendation (1, 2a, 2b, 3) which highlights the overall benefit of a treatment compared to its risks
I take it every day. CarnoSyn is also the only beta-alanine with New Dietary Ingredient (NDI) and self-affirmed GRAS status, which means it has undergone rigorous testing with the FDA and professional panels to achieve and maintain these certifications
Customer ratings and testimonials are brand-reported, not independently audited
GLP-1 medications may increase SIBO risk because slowed gastric emptying can alter the normal flow patterns that keep bacteria where they belong
"Looking forward, there could also be potential for long-term remediation, addressing the metabolic fallout and nutritional deficiencies in patients who have used these drugs improperly for years without monitoring
Your provider can help determine if testing is recommended
